Immune checkpoint inhibitors and the cardiovascular system: Reflecting on the past and looking towards the future

被引：0
|
作者：
Baik, Alan H. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, Div Cardiol, Sect Cardiooncol & Immunol, San Francisco, CA 94143 USA
来源：
TRENDS IN CARDIOVASCULAR MEDICINE | 2024年 / 34卷 / 02期
关键词：
D O I：
10.1016/j.tcm.2022.10.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitors: acute and chronic cardiovascular complications
    Josan, Kiranbir
    Neilan, Tomas G.
    NATURE REVIEWS CARDIOLOGY, 2023, 20 (02) : 73 - 74
  • [42] What about cardiovascular toxicities of immune checkpoint inhibitors?
    Moreno Diaz, Raquel
    Cazalla Garcia, Mario
    Bautista Sanz, Maria Pilar
    Gonzalez Davia, Rosa
    Rosero Rodriguez, Adriana Carolina
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (01) : 2 - 3
  • [43] Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
    Zhang, Zeng
    Tan, Xin
    Jiang, Zengxin
    Wang, Hao
    Yuan, Hengfeng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Future directions in immune-checkpoint inhibitors in NSCLC
    Hayashi, Hidetoshi
    CANCER SCIENCE, 2018, 109 : 1225 - 1225
  • [45] English in Thailand: looking back to the past, at the present and towards the future
    Trakulkasemsuk, Wannapa
    ASIAN ENGLISHES, 2018, 20 (02) : 96 - 105
  • [46] Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
    L'Orphelin, Jean-Matthieu
    Dollalille, Charles
    Akroun, Julia
    Alexandre, Joachim
    Dompmartin, Anne
    CANCERS, 2023, 15 (07)
  • [47] Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
    Flora Pirozzi
    Remo Poto
    Luisa Aran
    Alessandra Cuomo
    Maria Rosaria Galdiero
    Giuseppe Spadaro
    Pasquale Abete
    Domenico Bonaduce
    Gianni Marone
    Carlo Gabriele Tocchetti
    Gilda Varricchi
    Valentina Mercurio
    Current Oncology Reports, 2021, 23
  • [48] Retrospective Analysis of Cardiovascular Events With the Use of Immune Checkpoint Inhibitors
    Tarun, Tushar
    Bostick, Brian P.
    Baswaraj, Deepa
    Basra, Nishchayjit
    Khan, Meeshal
    Bickel, Trent
    CIRCULATION, 2020, 142
  • [49] Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors
    Laenens, D.
    Yu, Y.
    Santens, B.
    Jacobs, J.
    Beuselinck, B.
    Bechter, O.
    Wauters, E.
    Staessen, J.
    Janssens, S.
    Van Aelst, L.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2565 - 2565
  • [50] Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
    Pirozzi, Flora
    Poto, Remo
    Aran, Luisa
    Cuomo, Alessandra
    Galdiero, Maria Rosaria
    Spadaro, Giuseppe
    Abete, Pasquale
    Bonaduce, Domenico
    Marone, Gianni
    Tocchetti, Carlo Gabriele
    Varricchi, Gilda
    Mercurio, Valentina
    CURRENT ONCOLOGY REPORTS, 2021, 23 (02)
12345